Market Overview

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

21.90 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/07/19Stifel NicolausDowngradesHold23.0
11/06/19JefferiesDowngradesHold
12/17/18MizuhoMaintainsBuy63.0
11/12/18B. Riley FBRMaintainsBuy65.0
9/18/18MizuhoInitiates Coverage OnBuy61.0
8/09/18JefferiesMaintainsBuy58.0
5/25/18Stifel NicolausMaintainsBuy60.0
2/01/18BerenbergInitiates Coverage OnBuy66.0
12/04/17Janney CapitalUpgradesBuy
11/08/17B. Riley FBRMaintainsBuy50.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter